Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease which affects 3 million people worldwide.
Durvalumab improves long-term outcome in TNBC: results from the phase II randomized GeparNUEVO study investigating neodjuvant durvalumab in addition to an anthracycline/taxane based neoadjuvant ...
In a recent study published in Jama Network, researchers investigated the impact of coronavirus disease 2019 (COVID-19) on biomarkers in the cerebrospinal fluid (CSF). Study: Viral Antigen and ...
Sequencing circulating tumor cell-free DNA (cfDNA) in cerebrospinal fluid (CSF) improved diagnosis, decision-making, and clinical care in pediatric and adolescent and young adult (AYA) patients with ...
Director, Molecular Microbiology Assistant Director, Clinical Microbiology and Immunoserology Laboratories Nationwide Children's Hospital Associate Professor - Clinical, College of Medicine, The Ohio ...
In addition to brain imaging, laboratory analysis of cerebrospinal fluid is important for the diagnosis of multiple sclerosis (MS). In this study, proteomic analysis of this fluid has revealed a set ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results